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ABSTRACT: Trauma and loss of cochlear inner hair cells causes a series of
events that result first in the retraction of the peripheral processes of the audi-
tory nerve, scar formation in the organ of Corti, and over the course of weeks to
months (depending on the species) the loss of auditory nerve cell bodies (spiral
ganglion cells). Neurotrophic factors play an important role in the mature ner-
vous system as survival factors for maintenance and protection and also can
play a role in regrowth. Studies in the cochlea now show that application of ex-
ogenous neurotrophic factors can enhance survival of spiral ganglion cells after
deafness and induce regrowth of peripheral processes, perhaps by replacing lost
endogenous factors. Combinations of factors may be most effective for achiev-
ing greatest survival and regrowth. Our studies find that brain-derived neu-
rotrophic factor (BDNF) and glial-line-derived neurotrophic factor (GDNF) are
very effective at enhancing spiral ganglion cell survival following deafness from
ototoxic drugs or noise. It has also been found that BDNF plus fibroblast
growth factor (FGF) is very effective at inducing process regrowth. Electrical
stimulation also acts to enhance spiral ganglion cell survival, and the combina-
tion of electrical stimulation and neurotrophic factors could prove a most effec-
tive intervention.
Deafness with the loss of inner hair cells (IHC) results in progressive pathophysi-
ological changes that can end in the degeneration of most auditory nerve neurons. It
is now possible to consider these events in the broader context of antiapoptotic sur-
vival factors in the peripheral and central nervous system. One possible consequence
of the loss of sensory or neural elements can be a loss of support or survival factors
necessary for the target cells. The absence of these factors can cause changes ranging
from the downregulation of normal function to the initiation of biochemical cascades
leading to cell death through apoptosis or necrosis. The impact of deafferentation on
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the target cells appears to depend upon the extent to which other supporting inputs
(and their survival factors) are available, and with the loss of an exclusive input, tar-
get cells typically die (for review, see reference 1).
For the auditory nerve, the cell death that normally follows complete loss of sen-
sory cells2–5 can be prevented by chronic direct electrical activation of the auditory
nerve with cochlear prostheses.6–8 Moreover, the stimulation is effective even when
provided for only brief (30 min) intermittent periods (once per week), if at sufficient-
ly high intensities.9 These intensities are sufficient to express the intermediate–early
gene C-fos10 which, in turn, can initiate transcription of antiapoptotic genes and path-
ways. This activity can also upregulate products that act in an autocrine manner to
protect the nerve from death. Additionally, when propagated action potentials are
blocked by tetrodotoxin in models, the auditory nerve cannot be rescued from cell
death.9
It is now clear that neurotrophic factors function not only as growth, survival, pro-
liferative, and differentiation factors during development but also in maintaining the
mature nervous system, particularly the mature system under stress.1 The specific
mechanism of their action is not clear, but it involves receptor tyrosine kinase-acti-
vated intracellular cascades, probably involving Ras-MAP kinase and/or PI-3 kinase.
These pathways might play a role in intracellular ion homeostasis, particularly in the
maintenance of intracellular Ca2+ concentration at an appropriate level, and in the
regulation of antiapoptotic factors, such as Bcl-2.11
Many neurotrophic factors and their receptors have been identified in the mam-
malian cochlea. IHCs are a potential source of neurotrophic factors to the auditory
nerve. Expression of neurotrophin 3 (NT-3)12,13 and glial cell line-derived neu-
rotrophic factor (GDNF)14 have been identified in hair cells. A neurotrophic factor
might also be released from the auditory nerve and act in an autocrine fashion. Brain-
derived neurotrophic factor (BDNF),15 NT-3,12 GDNF,14 and acidic fibroblast growth
factor (aFGF)16 are all expressed in the auditory nerve. Hegarty and colleagues15
have provided in vitro evidence for a spiral ganglion cell (SGC) autocrine loop of
neurotrophic factors induced by depolarization. FGF has been demonstrated to be
upregulated under conditions of oxidative stress.17 The receptors for BDNF and NT-3
(trk b and trk c, respectively), as well as the GDNFR- component of the GDNF re-
ceptor complex,14 have been identified in the auditory nerve,12 although evidence for
c-Ret (the membrane-spanning component of the receptor complex) was not found.
The receptor for FGF has been identified in supporting cells.17
In vitro studies have demonstrated enhanced survival of SGC with a variety of
neurotrophic factors, including BDNF and NT-3 and an interaction of these factors
with potassium-induced depolarization or leukemia inhibitory factor.15,18 The devel-
opment of chronic local delivery systems, such as miniosmotic pumps and microcan-
nulation of the inner ear19 and viral vectors,20 have made it possible to evaluate the in
vivo efficacy of these neurotrophic factors. Two deafness models have been evaluated
in in vivo animal studies. One is an ototoxicity model, using a single aminoglycoside
or a combination of an aminoglycoside and ethacrynic acid. In this model,
BDNF,21,22 NT-3,22,23 nerve growth factor (NGF),24,25 and GDNF26 have been shown
to enhance SGC survival after deafness. In our studies9,26 we found that BDNF and
GDNF are the most effective and are comparably effective, either singly or combined
with other neurotrophic factors (FIG. 1). GDNF is effective at lower dosages than
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BDNF. We found that ciliary neurotrophic factor (CNTF) and FGF are not effective
in enhancing SGC survival, and that NT-3 provides only a slight improvement.
The most dramatic effect in enhancing SGC survival after deafness was with
GDNF in a second deafness model, noise overstimulation. Following the broad de-
struction of inner IHC and outer hair cells (OHC) (essentially the upper 25% of the
basal turn of the cochlea through the entire second turn) by intense noise exposure,
SGCs were rescued from cell death with the chronic, local application of a moderate-
ly high concentration of GDNF.14 In this study, eight subjects were exposed to one-
third octave-band noise (4-kHz center frequency, 130-dB SPL) for 5 h. This exposure
produced an auditory brain-stem response threshold shift of 70–80 dB at 2, 4, 6, 8,
and 20 kHz and, across all subjects, the wide destruction of OHC and IHC, extending
from the upper 25% of the basal turn through the second turn. Three days following
noise exposure, these subjects were implanted with a microcannula of the scala tym-
pani attached to a miniosmotic pump (Alzet®), delivering GDNF (100–144 g/mL,
n = 6) or artificial perilymph (AP, n = 2) for three weeks at 0.5 L/h. Midmodiolar
sections were taken from these subjects, and SGC survival was compared in the
GDNF-treated, AP-treated, and contralateral untreated ears and in 8 ears from 4 non-
exposed normal subjects. SGCs were sampled from four sites, representing the upper
basal turn and lower, middle, and upper second turn. No difference in SGC survival
was observed between AP-treated and nontreated noise-exposed ears, hence these
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FIGURE 1. The relative efficacy of intrascalar infusion of different neurotrophic factor treat-
ments in enhancing SGC survival in the basal turn of the guinea pig cochlear spiral, after bilat-
eral deafness from systemic kanamcyin and ethacrynic acid. AP—artificial perilymph;
BDNF—brain-derived neurotrophic factor; NT3—neurotrophin 3; GDNF—glial cell line-de-
rived neurotrophic factor; Cocktail—combination of BDNF, NT3, GDNF, and CNTF. In each
group of animals, SGC numbers in the basal turn reference area is compared to the contralater-
al untreated side. The top line shows SGC number in the normal cochlea.
groups were combined. FIGURE 2 illustrates the SGC survival in the GDNF- and non-
GDNF-treated noise-exposed ears as a percent of SGCs observed in nonexposed
ears. Compared to SGC survival ranging from 21% to 50% in the noise-exposed con-
trol ears, GDNF-treated ears showed survival ranges of 79 to 98% of normal. The ef-
fectiveness of GDNF in SGC preservation was remarkable in this study, but the inter-
pretation is not unambiguous because of the potential presence of other survival fac-
tors in the remaining basal and apical organ of Corti of these subjects.
One of the initial events following IHC trauma or loss is the swelling and regres-
sion of auditory nerve peripheral processes. It has been shown that when the IHC is
healthy, these processes can regrow and reconnect.27,28 After complete IHC loss,
there is no regrowth to the IHC region, although Bohne and Harding29 report re-
growth when there are regions with remaining IHCs. Thus, neurotrophic factors can
play a role in SGC process regrowth as well as in SGC survival. Many of the studies
examining neurotrophic factor enhancement of SGC survival have, indeed, reported
regrowth, particularly after BDNF and/or NT-3 infusion.9,22,23 We used GAP-439 to
identify the regrowth of auditory fibers, curving under the ossious spiral lamina into
scala tympani, in ears chronically treated with BDNF (50 ng/mL) + NT-3 (50 ng/mL)
+ GDNF (10 ng/mL) + CNTF (50 ng/mL). We are also using pan-trk receptor im-
munolabeling of peripheral processes to compare and contrast the efficacy of differ-
ent neurotrophic factors, singly or in combination. While BDNF alone induced
process regrowth, the richest and most extended labeling into the region of the previ-
ous organ of Corti was with BDNF + aFGF. aFGF alone was less effective, with few-
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FIGURE 2. Comparison of spiral ganglion cell (SGC) survival after noise overstimulation in
cochleae treated (intrascalar infusion) with glial cell line-derived neurotrophic factor (GDNF)
and cochleae treated with artificial perilymph (AP). Enhanced SGC survival is seen in the
treated side in three reference areas in the middle turn of the guinea pig cochlear spiral and a
reference area in the upper basal turn. SGC survival is expressed as a percent of normal (line
for 100% percent is shown over bars).
er processes and less growth into the organ of Corti region. Moreover, while CNTF
was least effective as a survival factor, a few processes were observed extending into
the region of the organ of Corti. Clearly, the poor effect of CNTF and FGF as SGC
survival factors would reduce their efficacy in inducing regrowth since they would
have little effect on dead or dying SGCs. This could explain the effectiveness of the
BDNF and FGF combination, with BDNF functioning both as a survival factor and
for regrowth, and with FGF influencing regrowth.
There is, therefore, compelling evidence that it is possible to intervene in the deaf
cochlea to enhance the survival of the auditory nerve as well as to induce regrowth of
peripheral processes. This will be important in the future if and when it becomes pos-
sible to induce regeneration of cochlear hair cells, which would still need the audito-
ry nerve to transmit auditory information centrally. Of more immediate interest, en-
hancement of auditory nerve survival is also essential to provide optimal perfor-
mance of cochlear prostheses.
The cochlear prosthesis now provides an effective treatment for the profoundly
deaf and, importantly, it is being applied with remarkable success in young children.
One significant element in cochlear prosthesis success is the survival of the auditory
nerve, which the prosthesis directly stimulates to send acoustic information to the
brain. Yet the physiological processes associated with profound sensorineural deaf-
ness, the defining condition for implant candidacy, lead to auditory nerve cell death.
The studies and results discussed previously suggest that there are effective ways to
prevent this neuronal loss. Moreover, while there is no compelling clinical evidence
to indicate that cochlear prostheses’ benefits increase with the survival of the eighth
nerve peripheral processes, there are model data and physiological evidence that this
is the case.30–33 The contact of individual nerve fibers with discrete stimulation sites
on a cochlear prosthesis should lead to lower thresholds, increased dynamic range of
function, and greater selectivity of excitation. These features surely increase our ca-
pabilities of individualizing speech processor programs, and this should lead to
greater benefits of the cochlear prosthesis.
A future generation of cochlear prosthesis might have features for neurotrophic
factor delivery, such as factor delivery channels and/or biopolymer coatings to deliv-
er factors or provide a matrix for genetically altered cells to generate them. Such fac-
tors can be provided in combination and in sequence to maintain cell survival, to ini-
tiate peripheral process-directed regrowth, and to provide a target and maintenance
factor. These factors then will engineer the tissues of the inner ear to optimize the
prosthesis–tissue interface and the perceptual benefits provided by a future genera-
tion of implants.
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